HIV/AIDS Research
U.S. NIH awards $32 million contract for ongoing HIV vaccine research
Published in AIDS Weekly, January 2nd, 2006
Wyeth Pharmaceuticals, the pharmaceutical division of Wyeth (WYE), has been awarded a 5-year, $32 million contract from the Division of AIDS of the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), for the development of therapeutic HIV vaccines in conjunction with researchers at the University of Pennsylvania, Duke University, and Beth Israel/Deaconess Hospital in New York City.
Through the HIV Vaccine Design and Development Teams (HVDDT) program, Wyeth will develop and clinically evaluate novel adjuvant-enhanced plasmid DNA (pDNA) and peptide based vaccines for use in a prime-boost therapeutic regimen...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-02)
More Articles from AIDS Weekly
- Disease Associations
HIV-infected nonimmune adults are at increased risk of severe malaria - HIV/AIDS HAART
Replication-competent HIV persists in patients with uninterrupted HAART - HIV/AIDS Research
Health Canada grants approval for first-in-man clinical trial of treatment of drug resistant HIV - HIV/AIDS Therapy
Interruptions of shorter periods are unlikely to allow restoration of mitochondrial DNA - HIV/AIDS-Related Cancer
HIV-1 disease length and not immune status is a risk factor for anal carcinoma development - Diet & Nutrition
Trial final results show Resurgex reduces oxidative stress and enhances performance - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
